Hedge Fund - Palo Alto Investors
Amicus Therapeutics Inc. (FOLD)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2023 - Q4 (2023-12-31) | $147,203,016 | 13.26% | 10,373,715 | $11.35 |
| 2 | 2023 - Q3 (2023-09-30) | $127,972,108 | 12.1% | 10,524,022 | $12.90 |
| 3 | 2023 - Q2 (2023-06-30) | $132,181,716 | 10.67% | 10,524,022 | $11.87 |
| 4 | 2023 - Q1 (2023-03-31) | $116,711,404 | 9.66% | 10,524,022 | $12.33 |
| 5 | 2022 - Q4 (2022-12-31) | $128,128,346 | 10.92% | 10,493,722 | $11.26 |
| 6 | 2022 - Q3 (2022-09-30) | $102,811,000 | 8.12% | 9,847,774 | $11.14 |
| 7 | 2022 - Q2 (2022-06-30) | $105,765,000 | 9.21% | 9,847,774 | $8.24 |
| 8 | 2022 - Q1 (2022-03-31) | $93,789,000 | 7.25% | 9,903,761 | $9.38 |
| 9 | 2021 - Q4 (2021-12-31) | $116,817,000 | 7.46% | 10,114,043 | $11.14 |
| 10 | 2021 - Q3 (2021-09-30) | $96,589,000 | 5.82% | 10,114,043 | $10.23 |
| 11 | 2021 - Q2 (2021-06-30) | $96,424,000 | 5.31% | 10,002,443 | $9.76 |
| 12 | 2021 - Q1 (2021-03-31) | $96,439,000 | 5.49% | 9,761,043 | $15.48 |
| 13 | 2020 - Q4 (2020-12-31) | $181,652,000 | 9.52% | 7,867,114 | $20.45 |
| 14 | 2020 - Q3 (2020-09-30) | $111,084,000 | 6.09% | 7,867,114 | $14.57 |
| 15 | 2020 - Q2 (2020-06-30) | $110,607,000 | 6.64% | 7,334,714 | $12.19 |
| 16 | 2020 - Q1 (2020-03-31) | $68,816,000 | 5.76% | 7,447,618 | $9.51 |
| 17 | 2019 - Q4 (2019-12-31) | $72,212,000 | 3.97% | 7,413,920 | $9.15 |
| 18 | 2019 - Q3 (2019-09-30) | $57,447,000 | 3.82% | 7,162,920 | $10.85 |
| 19 | 2019 - Q2 (2019-06-30) | $97,298,000 | 4.73% | 7,796,299 | $12.69 |
| 20 | 2019 - Q1 (2019-03-31) | $103,630,000 | 4.32% | 7,619,833 | $12.22 |
| 21 | 2018 - Q4 (2018-12-31) | $70,905,000 | 3.77% | 7,401,321 | $10.99 |
| 22 | 2018 - Q3 (2018-09-30) | $76,967,000 | 3.11% | 6,366,147 | $13.98 |
| 23 | 2018 - Q2 (2018-06-30) | $96,350,000 | 3.85% | 6,168,347 | $15.12 |
| 24 | 2018 - Q1 (2018-03-31) | $92,463,000 | 3.95% | 6,147,829 | $15.22 |
| 25 | 2017 - Q4 (2017-12-31) | $86,427,000 | 3.72% | 6,006,022 | $13.74 |
| 26 | 2017 - Q3 (2017-09-30) | $111,898,000 | 4.71% | 7,420,288 | $13.23 |
| 27 | 2017 - Q2 (2017-06-30) | $79,964,000 | 3.73% | 7,940,788 | $8.05 |
| 28 | 2017 - Q1 (2017-03-31) | $56,206,000 | 2.65% | 7,882,988 | $6.32 |
| 29 | 2016 - Q4 (2016-12-31) | $31,858,000 | 1.81% | 6,410,030 | $6.92 |
| 30 | 2016 - Q3 (2016-09-30) | $42,072,000 | 2.44% | 5,685,388 | $6.75 |
| 31 | 2016 - Q2 (2016-06-30) | $21,891,000 | 1.65% | 4,009,375 | $6.99 |
| 32 | 2016 - Q1 (2016-03-31) | $30,007,000 | 2.32% | 3,551,173 | $7.08 |
| 33 | 2015 - Q4 (2015-12-31) | $34,446,000 | 1.91% | 3,551,173 | $9.01 |
| 34 | 2015 - Q3 (2015-09-30) | $27,622,000 | 1.32% | 1,974,376 | $15.68 |
| 35 | 2015 - Q2 (2015-06-30) | $27,937,000 | 1.24% | 1,974,376 | $12.02 |
| 36 | 2015 - Q1 (2015-03-31) | $21,285,000 | 1.05% | 1,956,376 | $8.81 |
| 37 | 2014 - Q4 (2014-12-31) | $16,277,000 | 0.95% | 1,956,376 | $6.86 |
| 38 | 2014 - Q3 (2014-09-30) | $11,640,000 | 0.86% | 1,956,376 | $5.24 |
| 39 | 2014 - Q2 (2014-06-30) | $13,265,000 | 0.98% | 3,971,576 | $2.35 |
| 40 | 2014 - Q1 (2014-03-31) | $8,221,000 | 0.67% | 3,971,576 | $2.50 |
| 41 | 2013 - Q4 (2013-12-31) | $9,420,000 | 0.87% | 4,008,576 | $2.20 |
| 42 | 2013 - Q3 (2013-09-30) | $10,724,000 | 1.12% | 4,622,230 | $2.51 |
| 43 | 2013 - Q2 (2013-06-30) | $10,770,000 | 1.27% | 4,622,230 | $3.07 |
| 44 | 2013 - Q1 (2013-03-31) | $15,155,000 | 1.79% | 4,780,670 | $3.38 |
| 45 | 2012 - Q4 (2012-12-31) | $12,812,000 | 1.5% | 4,780,670 | $5.04 |
| 46 | 2012 - Q3 (2012-09-30) | $28,217,000 | 2.78% | 5,426,270 | $5.33 |
| 47 | 2012 - Q1 (2012-03-31) | $30,161,000 | 3.3% | 5,712,284 | $5.75 |
| 48 | 2011 - Q4 (2011-12-31) | $20,028,000 | 2.24% | 5,821,954 | $3.25 |
| 49 | 2011 - Q3 (2011-09-30) | $22,549,000 | 2.91% | 5,872,133 | $5.19 |
| 50 | 2011 - Q2 (2011-06-30) | $38,057,000 | 3.94% | 6,406,833 | $6.98 |
The displayed share prices are average quarterly stock market prices.